Tumor bioengineering using a transglutaminase crosslinked hydrogel

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Fang, Josephine Y ^a   Tan, Shih Jye ^a   Yang, Zhi ^a   Tayag, Charisse ^a   Han, Bo ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATIN; GELATIN GEL; PACLITAXEL; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG; COLLAGEN; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HYDROGEL; IC 50; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REPRODUCIBILITY; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; COCULTURE; CULTURE TECHNIQUE; DRUG SCREENING; ENZYMOLOGY; METABOLISM; MULTICELLULAR SPHEROID; NEOPLASM; NUDE MOUSE; PROCEDURES; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COCULTURE TECHNIQUES; COLLAGEN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROGELS; MICE, NUDE; NEOPLASMS; SPHEROIDS, CELLULAR; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84940225690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105616     Document Type: Article

References (67)

1. Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited - The role of tumor - stroma interactions in metastasis to different organs. International Journal of Cancer 128: 2527-2535.
2. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601-610. (Pubitemid 47268064)
3. Stroock AD, Fischbach C (2010) Microfluidic culture models of tumor angiogenesis. Tissue Engineering Part A 16: 2143-2146.
4. Baker BM, Chen CS (2012) Deconstructing the third dimension-how 3D culture microenvironments alter cellular cues. Journal of Cell Science 125: 3015-3024.
5. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, et al. (2007) Engineering tumors with 3D scaffolds. Nature Methods 4: 855-860. (Pubitemid 350055585)
6. Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Seminar in Cancer Biology 15: 365-377.
7. Nyga A, Cheema U, Loizidou M (2011) 3D tumour models: novel in vitro approaches to cancer studies. Journal of cell communication and signaling 5: 239-248.
8. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, et al. (2009) Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proceedings of the National Academy of Sciences 106: 399-404.
9. Ghajar CM, Bissell MJ (2010) Tumor engineering: the other face of tissue engineering. Tissue Engineering Part A 16: 2153-2156.
10. Constantinou AI, Krygier AE, Mehta RR (1998) Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. The American journal of clinical nutrition 68: 1426S-1430S. (Pubitemid 28550924)
11. Ong S-M, Zhao Z, Arooz T, Zhao D, Zhang S, et al. (2010) Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomaterials 31: 1180-1190.
12. Timmins NE, Nielsen LK (2007) Generation of multicellular tumor spheroids by the hanging-drop method. Tissue Engineering: Springer. 141-151.
13. Albini A, Iwamoto Y, Kleinman H, Martin G, Aaronson S, et al. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research 47: 3239-3245. (Pubitemid 17082655)
14. Passaniti A, Isaacs JT, Haney JA, Adler SW, Cujdik TJ, et al. (1992) Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. International Journal of Cancer 51: 318-324.
15. Miller BE, Miller FR, Heppner GH (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Research 45: 4200-4205. (Pubitemid 16224874)
16. Doillon CJ, Gagnon E, Paradis R, Koutsilieris M (2004) Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity. Anticancer Research 24: 2169-2178.
17. Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC (2009) Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30: 6076-6085.
18. Kibbey MC, Grant DS, Kleinman HK (1992) Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. Journal of the National Cancer Institute 84: 1633-1638.
19. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
20. Sung S-Y, Hsieh C-L, Wu D, Chung LW, Johnstone PA (2007) Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Current problems in cancer 31: 36-100. (Pubitemid 46386278)
21. Szot CS, Buchanan CF, Freeman JW, Rylander MN (2011) 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 32: 7905-7912.
22. Kuwahara K, Yang Z, Slack GC, Nimni ME, Han B (2009) Cell delivery using an injectable and adhesive transglutaminase-gelatin gel. Tissue Engineering Part C: Methods 16: 609-618.
23. Kuwahara K, Fang JY, Yang Z, Han B (2011) Enzymatic crosslinking and degradation of gelatin as a switch for bone morphogenetic protein-2 activity. Tissue Engineering Part A 17: 2955-2964.
24. Fang J, Yang Z, Tan S, Tayag C, Nimni ME, et al. (2014) Injectable gel graft for bone defect repair. Regenerative medicine 9: 41-51.
25. Trédan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute 99: 1441-1454.
26. Ungefroren H, Sebens S, Groth S, Gieseler F, Fandrich F (2011) The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Current Cancer Drug Targets 11: 524-535.
27. Su S, Chang Y, Andreu-Vieyra C, Fang J, Yang Z, et al. (2012) miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene.
28. Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, et al. (2006) EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. International Journal of Cancer 119: 1236-1248. (Pubitemid 44258795)
29. Gordon EM, Michael S, Kundu RK, Han B, Andrades J, et al. (1997) Capture and Expansion of Bone Marrow-Derived Mesenchymal Progenitor Cells with a Transforming Growth Factor-b1-von Willebrand's Factor Fusion Protein for Retrovirus-Mediated Delivery of Coagulation Factor IX. Human Gene Therapy 8: 1385-1394. (Pubitemid 27445419)
30. Ahearne M, Yang Y, Liu K (2008) Mechanical characterisation of hydrogels for tissue engineering applications. Topics in tissue Engineering 4: 1-16.
31. Yang Y, Bagnaninchi PO, Ahearne M, Wang RK, Liu K-K (2007) A novel optical coherence tomography-based micro-indentation technique for mechanical characterization of hydrogels. Journal of the Royal Society Interface 4: 1169-1173. (Pubitemid 350303859)
32. Chau D, Collighan RJ, Verderio EA, Addy VL, Griffin M (2005) The cellular response to transglutaminase-cross-linked collagen. Biomaterials 26: 6518-6529. (Pubitemid 41021746)
33. Davis GE, Bayless KJ, Davis MJ, Meininger GA (2000) Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. The American Journal of Pathology 156: 1489-1498. (Pubitemid 30646688)
34. Kilian KA, Bugarija B, Lahn BT, Mrksich M (2010) Geometric cues for directing the differentiation of mesenchymal stem cells. Proceedings of the National Academy of Sciences 107: 4872-4877.
35. Wulf E, Deboben A, Bautz F, Faulstich H, Wieland T (1979) Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proceedings of the National Academy of Sciences 76: 4498-4502. (Pubitemid 9256508)
36. Tilghman RW, Blais EM, Cowan CR, Sherman NE, Grigera PR, et al. (2012) Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis. PLoS One 7: e37231.
37. Agastin S, Giang U-BT, Geng Y, DeLouise LA, King MR (2011) Continuously perfused microbubble array for 3D tumor spheroid model. Biomicrofluidics 5: 024110.
38. Talukdar S, Mandal M, Hutmacher DW, Russell PJ, Soekmadji C, et al. (2011) Engineered silk fibroin protein 3D matrices for in vitro tumor model. Biomaterials 32: 2149-2159.
39. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, et al. (2010) Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31: 8494-8506.
40. Bradbury P, Fabry B, O'Neill GM (2012) Occupy tissue: The movement in cancer metastasis. Cell adhesion & migration 6: 424-520.
41. Fraley SI, Feng Y, Krishnamurthy R, Kim D-H, Celedon A, et al. (2010) A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nature cell biology 12: 598-604.
42. Iglesias JM, Beloqui I, Garcia-Garcia F, Leis O, Vazquez-Martin A, et al. (2013) Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin. PloS one 8: e77281.
43. Ivascu A, Kubbies M (2006) Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. Journal of biomolecular screening 11: 922-932. (Pubitemid 44847146)
44. Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. International journal of oncology 31: 1403-1414.
45. Evans CL, Abu-Yousif AO, Park YJ, Klein OJ, Celli JP, et al. (2011) Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS ONE 6: e23434.
46. Büchler P, Reber HA, Lavey RS, Tomlinson J, Büchler MW, et al. (2004) Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model 1. Journal of Surgical Research 120: 295-303. (Pubitemid 38834199)
47. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer and Metastasis Reviews 26: 225-239. (Pubitemid 47101660)
48. Brammer I, Zywietz F, Jung H (1979) Changes of histological and proliferative indices in the Walker carcinoma with tumour size and distance from blood vessel. European Journal of Cancer (1965) 15: 1329-1336.
49. Rajendran JG, Krohn KA (2005) Imaging hypoxia and angiogenesis in tumors. Radiologic Clinics of North America 43: 169-187. (Pubitemid 40326567)
50. Crescenzi V, Francescangeli A, Taglienti A (2002) New gelatin-based hydrogels via enzymatic networking. Biomacromolecules 3: 1384-1391. (Pubitemid 35428777)
51. Barcus CE, Keely PJ, Eliceiri KW, Schuler LA (2013) Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. Journal of Biological Chemistry 288: 12722-12732.
52. Baker EL, Lu J, Yu D, Bonnecaze RT, Zaman MH (2010) Cancer cell stiffness: integrated roles of three-dimensional matrix stiffness and transforming potential. Biophysical Journal 99: 2048-2057.
53. Hakkinen KM, Harunaga JS, Doyle AD, Yamada KM (2010) Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Engineering Part A 17: 713-724.
54. Ma L, Zhou C, Lin B, Li W (2010) A porous 3D cell culture micro device for cell migration study. Biomedical microdevices 12: 753-760.
55. Zaman MH, Trapani LM, Sieminski AL, MacKellar D, Gong H, et al. (2006) Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proceedings of the National Academy of Sciences 103: 10889-10894. (Pubitemid 44148391)
56. PaszeK MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer cell 8: 241-254. (Pubitemid 41317594)
57. Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, et al. (2003) Autocrine laminin-5 ligates a6b4 integrin and activates RAC and NFkB to mediate anchorage-independent survival of mammary tumors. The Journal of cell biology 163: 1397-1407. (Pubitemid 38032099)
58. Pirazzoli V, Ferraris GMS, Sidenius N (2013) Direct evidence of the importance of vitronectin and its interaction with the urokinase receptor in tumor growth. Blood 121: 2316-2323.
59. Mao Y, Schwarzbauer JE (2005) Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. Journal of cell science 118: 4427-4436. (Pubitemid 41556341)
60. Chekenya M, Hjelstuen M, Enger PØ, Thorsen F, Jacob AL, et al. (2002) NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin. The FASEB Journal 16: 586-588.
61. Hendriks J, Planelles L, de Jong-Odding J, Hardenberg G, Pals S, et al. (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death & Differentiation 12: 637-648. (Pubitemid 40767166)
62. Saverio B, Pierpaola D, Serenella A, Cesare C, Bruno M, et al. (2000) Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Research 60: 28-34. (Pubitemid 30058724)
63. Ananthanarayanan B, Kim Y, Kumar S (2011) Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 32: 7913-7923.
64. Bissell MJ, LaBarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer cell 7: 17.
65. Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Reviews Immunology 7: 41-51. (Pubitemid 46020826)
66. Allavena P, Sica A, Solinas G, Porta C, Mantovani A (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Critical reviews in oncology/hematology 66: 1-9. (Pubitemid 351324128)
67. Whiteside T (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27: 5904-5912.